![Steve Innaimo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Steve Innaimo
Operationeel Directeur bij PORTAGE BIOTECH INC.
Vermogen: - $ op 31-05-2024
Actieve functies van Steve Innaimo
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PORTAGE BIOTECH INC. | Operationeel Directeur | 08-01-2019 | - |
Loopbaan van Steve Innaimo
Eerdere bekende functies van Steve Innaimo
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
COVANCE INC. | Directeur/Bestuurslid | 01-03-2017 | 01-10-2018 |
Corporate Officer/Principal | 01-03-2017 | 01-10-2018 | |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-08-1994 | 01-03-2017 |
Opleiding van Steve Innaimo
University of Connecticut | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
Operationeel
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Director/Board Member | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
PORTAGE BIOTECH INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Labcorp Drug Development, Inc.
![]() Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
- Beurs
- Insiders
- Steve Innaimo
- Ervaring